Study shows UK recall rise

Manufacturing missteps are behind the near quadrupling of drug and medical device recalls in the UK between 2004 and 2008. A study by marketing concern Blueview Group shows that recalls and product alerts climbed to 94 from just 22, with nearly two-thirds attributed to manufacturing defects.

The study finds that 12 percent of pharma recalls stem from labeling and packaging problems, according to an online report, while nine percent are due to compromised sterility.

Another finding: food product recalls have remained more stable during the rapid rise of pharma and non-food consumer product recalls and safety alerts.

- here's the report

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)